Showing session: reset
From Chemistry to the Clinic: Pathways for Drug Discovery and Development, Part 3: New Opportunities in Epigenetic Therapies
- Sort by:
- Browse by:
- Free
- audio + slides
- All slides included
Introduction
Guowei Fang
AbbVie, Inc., North Chicago, IL, United States
- Free
- audio + slides
- All slides included
Chemical probes for epigenetic proteins
Paul Brennan
University of Oxford, Oxford, United Kingdom
- Permission not
granted for presentation
Discovering chemical probes of histone methyltransferases
H. Ümit Kaniskan
Icahn School of Medicine at Mt. Sinai, New York, NY, United States
- Free
- Unknown permission
for presentation
Discovery of EPZ015666: A first-In-class PRMT5 inhibitor with potent in vitroand in vivo activity
Kenneth W. Duncan
Epizyme, Inc., Cambridge, MA, United States